Innovative Compounds and Inhibitors Paving the Way for Advanced Tuberculosis Treatments
Researchers have developed a promising new compound, CMX410, that targets a vital enzyme in tuberculosis bacteria, showing effectiveness against drug-resistant strains and offering hope for improved treatments for the deadliest infectious disease.